As many high-income countries are relaxing restrictions for the summer months, low- and middle-income countries (LMICs) are witnessing rises in cases, deaths, and overwhelmed hospitals.  Countries in Europe and the United States are increasingly allowing in travellers, ending mask mandates, and allowing large gatherings including football matches and concerts.  At the same time, the third […] Continue reading ->
Despite a series of controversies, Bharat Biotech, which produces Indian homegrown vaccine Covaxin, hopes for World Health Organization (WHO) emergency use listing (EUL) soon, following last week’s publication of its promising Phase 3 results. The vaccine was given emergency authorisation by the Indian government in early January – even before it had concluded a Phase […] Continue reading ->
Despite the emergence of new WHO concerns over quality control at Sputnik V’s domestic production facilities, the Russian Direct Investment Fund (RDIF) is pushing ahead with a massive international “open-license” manufacturing effort for its Sputnik V vaccine – which breaks the traditional model of vaccine production and leverages existing capacity in poorer countries, desperate for […] Continue reading ->
The Biden administration has been asked to clarify that sanctions against Cuba would not extend to collaborations in the development, manufacturing, distribution and sale of COVID-19 vaccines that the island nation is in the process of developing. A memorandum, sent by Knowledge Ecology International (KEI) on 28 June to the White House, asks the US […] Continue reading ->
The African Union (AU) Special Envoy on COVID-19 has bluntly blamed the WHO co-sponsored COVAX facility for the dire vaccine shortage on the continent, saying that it had failed to disclose its vaccine supply problems early enough. Strive Masiyiwa, AU Special Envoy and head of the African COVID-19 Vaccine Acquisition Task Team (AVATT) said that […] Continue reading ->
African Union and WHO/African Region officials on Thursday sharply criticized the European Union decision to not grant the Indian version of AstraZeneca’s “Covishield” vaccine, distributed by the global COVAX facility, recognition in the new EU “Digital Green Pass programme” – amidst a growing chorus of global protests over the double standard. In a related statement, […] Continue reading ->